awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26796702-015370B9-2AEC-4DDE-9A07-389D9FBA0BAA
Q26796702-015370B9-2AEC-4DDE-9A07-389D9FBA0BAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796702-015370B9-2AEC-4DDE-9A07-389D9FBA0BAA
Therapeutic challenges in renal cell carcinoma
P2860
Q26796702-015370B9-2AEC-4DDE-9A07-389D9FBA0BAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796702-015370B9-2AEC-4DDE-9A07-389D9FBA0BAA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7927138b65dda0e8a66b97277fd6395092e710d
P2860
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.